Cited by 180Systemic Lupus Erythematosus ResearchReproductive System and PregnancyBlood Coagulation and Thrombosis Mechanisms

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss

Bramham, Kate, Thomas, Mari, Nelson-Piercy, Catherine, Khamashta, Munther, Hunt, Beverley J.·2011·Blood

DOI 10.1182/blood-2011-02-339234

Open this paper in CoChat — free account

Abstract

The objective of this study was to assess pregnancy outcome in women with a history of refractory antiphospholipid antibody-associated pregnancy loss(es) who were treated with early low-dose prednisolone in addition to aspirin and heparin. Eighteen women with antiphospholipid antibodies who had refractory pregnancy loss(es) were given prednisolone (10 mg) from the time of their positive pregnancy test to 14 weeks' gestation. Before low-dose prednisolone was given as treatment, 4 (4%) of 97 pregnancies had resulted in live births. Among 23 pregnancies supplemented with prednisolone, 9 women had 14 live births (61%), including 8 uncomplicated pregnancies. The remainder were complicated by preterm delivery, preeclampsia, and/or small-for-gestational-age infants. There were 8 first-trimester miscarriages and 1 ectopic pregnancy. There were no fetal deaths after 10 weeks' gestation and no evidence of maternal morbidity. The addition of first-trimester low-dose prednisolone to conventional treatment is worthy of further assessment in the management of refractory antiphospholipid antibody-related pregnancy loss(es), although complications remain elevated.

Integrity signals

Registry

Crossref · 10.1182/blood-2011-02-339234

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
MIYAKIS, S., LOCKSHIN, M. D., ATSUMI, T., BRANCH, D. W., BREY, R. L., CERVERA, R., DERKSEN, R. H. W. M., DE GROOT, P. G., KOIKE, T., MERONI, P. L., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01753.x · Cited by 7,203
THE CLASSIFICATION AND DIAGNOSIS OF THE HYPERTENSIVE DISORDERS OF PREGNANCY: STATEMENT FROM THE INTERNATIONAL SOCIETY FOR THE STUDY OF HYPERTENSION IN PREGNANCY (ISSHP)
Brown, M. A., Lindheimer, M. D., de Swiet, M., Assche, A. V., & Moutquin, J. (2001) · Hypertension in Pregnancy · doi:10.1081/prg-100104165 · Cited by 1,894
Antiphospholipid syndrome
Ruiz‐Irastorza, G., Crowther, M. A., Branch, W. D., & Khamashta, M. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60709-x · Cited by 875
Self-citation
Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activation
Girardi, G., Redecha, P. B., & Salmon, J. E. (2004) · Nature Medicine · doi:10.1038/nm1121 · Cited by 680
Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
Holers, V. M., Girardi, G., Mo, L., Guthridge, J. M., Molina, H. D., Pierangeli, S. S., Espinola, R. G., Xiaowei, L. E., Mao, D., Vialpando, C. G., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.200116116 · Cited by 625
Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment
Cowchock, F. S., Reece, E. A., Balaban, D. J., Branch, D. W., & Plouffe, L. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91596-3 · Cited by 585
Placental 11β‐hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure
Benediktsson, R., Calder, A. A., Edwards, C. R. W., & Seckl, J. R. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.1230939.x · Cited by 536
Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant
Empson, M. B., Lassere, M., Craig, J. C., & Scott, J. R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002859.pub2 · Cited by 486
Untitled work
(1992) · PubMed · Cited by 434
Prednisone and Aspirin in Women with Autoantibodies and Unexplained Recurrent Fetal Loss
Laskin, C. A., Bombardier, C., Hannah, M. E., Mandel, F. P., Ritchie, K., Farewell, V. T., Farine, D., Spitzer, K. A., Fielding, L. J., Soloninka, C. A., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370302 · Cited by 433

Show all 27 references

Sorted by citations

Items 101–180 of 180

What is the best time to assess the antiphospholipid antibodies (aPL) profile to better predict the obstetric outcome in antiphospholipid syndrome (APS) patients?
Latino, J. O., Udry, S., Wingeyer, S. D. P., Romero, D. F., Micone, P., & Larrañaga, G. F. D. (2018) · Immunologic Research · doi:10.1007/s12026-018-9024-5 · Cited by 9
Safety of Antenatal Predniso(lo)ne and Dexamethasone on Fetal, Neonatal and Childhood Outcomes: A Systematic Review
Slob, E. M. A., Termote, J. U. M., Nijkamp, J. W., van der Kamp, H. J., & van den Akker, E. L. T. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad547 · Cited by 8
Preeclampsia before fetal viability in women with primary antiphospholipid syndrome- materno-fetal outcomes in a series of 7 cases
Mayer-Pickel, K. I., Stern, C., Cervar-Zivkovic, M., Schöll, W., & Moertl, M. G. (2020) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2020.103101 · Cited by 8
Uterine CD56dim and CD16+ Cells in Refractory Antiphospholipid Antibody-Related Pregnancy Loss and Chromosomally Intact Abortuses: A Case-Control Study.
Gomaa, M. F., Elkhouly, A. G., Farghly, M. M., Farid, L. A., & Awad, N. (2017) · Europe PMC (PubMed Central) · doi:10.4103/jhrs.jhrs_65_16 · Cited by 8
Antiphospholipid syndrome characteristics and adverse pregnancy outcomes after 20 weeks of pregnancy
Gabbay‐Benziv, R., danieli, H. Z., Blickstein, D., Shmueli, A., Salman, L., & Hadar, E. (2018) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12511 · Cited by 8
Antiphospholipid Syndrome
Levine, A. B., & Lockshin, M. D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0673-4_6 · Cited by 7
Obstetric antiphospholipid syndrome
de Barros, V. I. P. V. L., Igai, A. M. K., de Oliveira, A. L. M. L., Teruchkin, M. M., & Orsi, F. A. (2021) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0041-1732382 · Cited by 6
Antiphospholipid syndrome and pregnancy
Arauz, J. F. R., Alonso, A. G., González, A. L. L., Velásquez, P. R., & Méndez, J. A. A. (2024) · Reumatizam · doi:10.33004/reumatizam-70-2-6 · Cited by 7
Antiphospholipid syndrome
Khamashta, M. A., & Amigo, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-09138-1.00139-x · Cited by 8
Self-citation
Can we cure antiphospholipid syndrome?
Meroni, P. L., Capobianco, E., & Tedesco, F. (2025) · Current Opinion in Immunology · doi:10.1016/j.coi.2025.102610 · Cited by 6
A Simplified Understanding of the Black Swan: Anti-phospholipid Antibody Syndrome
Vaidya, B., Nakarmi, S., Joshi, R., & Baral, R. (2019) · Journal of Nepal Medical Association · doi:10.31729/jnma.4226 · Cited by 6
Avances de interés clínico en el diagnóstico y tratamiento de los pacientes con síndrome antifosfolípido
García, J. L., & Khamashta, M. A. (2012) · Revista Clínica Española · doi:10.1016/j.rce.2012.04.003 · Cited by 6
Self-citation
Seronegative Obstetric Antiphospholipid Syndrome Finally Treated Successfully
Alghanim, K. K., Alrayes, H. A., & Aljurbua, R. M. (2022) · European Journal of Case Reports in Internal Medicine · doi:10.12890/2022_003686 · Cited by 5
The Role of Natural Killer Cells and Mast Cells in Female Infertility and Associated Treatment Outcomes
Lorzadeh, N., & Kazemirad, N. (2020) · Current Women s Health Reviews · doi:10.2174/1573404816666200206111550 · Cited by 5
The antiphospholipid syndrome
Barilaro, G., Espinosa, G., & Cervera, R. (2021) · Revista Colombiana de Reumatología · doi:10.1016/j.rcreu.2021.03.012 · Cited by 7
Clinical advances of interest in the diagnosis and treatment of patients with antiphospholipid syndrome
García, J. L., & Khamashta, M. A. (2013) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2012.04.001 · Cited by 5
Self-citation
Recommendations of the Spanish Rheumatology Society for primary antiphospholipid syndrome. Part II: Obstetric antiphospholipid syndrome and special situations
Cáliz, R., Fontecha, P. D. D. C., Galindo-Izquierdo, M., Longo, F. J. L., Zamora, M. Á. M., Santamaría, A., Pliego, O. A., Lozano, M. J. C., Beltrán, M. P. D., Ortells, L. C., et al. (2019) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2018.11.013 · Cited by 4
Risk factors for pregnancy failure in patients with antiphospholipid antibody positivity and prior pregnancy losses: A retrospective study
Duan, H., Li, X., Liu, C., Ge, Y., & Deng, X. (2020) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2020.103171 · Cited by 4
Clinical Practice Guidelines for the Management of Pregnancy in Women With Autoimmune Rheumatic Diseases of the Mexican College of Rheumatology. Part II
Salinas, M. Á. S., Barrera-Cruz, A., Castañeda, A. R. C., Quezada, L. J. J., Arce-Salinas, C. A., Álvarez-Nemegyei, J., Mouret, A. F., Alcalá, J. O., Páramo, M. S., Reyes, C. V. C., et al. (2015) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2015.03.005 · Cited by 4
Pregnancy in systemic autoimmune diseases: Myths, certainties and doubts
Danza, Ã., Ruiz‐Irastorza, G., & Khamashta, M. A. (2016) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2016.10.023 · Cited by 4
Self-citation
Pregnancy in antiphospholipid syndrome: can we improve patient management?
Nalli, C., & Tincani, A. (2014) · PubMed · Cited by 4
Response to: 'Correspondence on 'EULAR recommendations for the management of antiphospholipid syndrome in adults' by Zhou et al
Tektonidou, M. G., Tincani, A., & Ward, M. M. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-219048 · Cited by 4
Idiopathic Normal Pressure Hydrocephalus – What We Know
Baltatanu, D., & Berteanu, M. (2019) · MAEDICA – a Journal of Clinical Medicine · doi:10.26574/maedica.2019.14.2.161 · Cited by 4
A glimpse into the history of description of the antiphospholipid syndrome
Nour‐Eldine, W., Noureldine, H. A., Haydar, B. A., Eldine, M. N., Noureldine, M. H. A., & Uthman, I. W. (2020) · Lupus · doi:10.1177/0961203320947152 · Cited by 3
Antiphospholipid syndrome
Sciascia, S., Radin, M., & Schreiber, K. I. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23947-2.00045-x · Cited by 3
Combined Low Dose Aspirin and Steroids vs Aspirin Only in Management of Unexplained Recurrent Miscarriage
Omda, F. A.-E. E., El-Fattah, A. T. A., & Ragab, A. M. (2019) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2019.32989 · Cited by 3
Relationship of lupus nephritis and pregnancy: A narrative review
Elahi, T., Ahmed, S., & Mubarak, M. (2024) · World Journal of Nephrology · doi:10.5527/wjn.v13.i4.99700 · Cited by 2
Pregnancy Outcomes in Non-Criteria Obstetric Antiphospholipid Syndrome: Analysis of a Cohort of 91 Patients
Beça, S., Baños, N., Borrell, M., Ruiz‐Ortiz, E., Pérez-Isidro, A., Cervera, R., Reverter, J. C., Tàssies, D., & Espinosa, G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13247862 · Cited by 2
Antiphospholipid Antibodies and Syndrome: Complexities in Diagnosis and Management
Schreiber, K. I., Sciascia, S., & Hunt, B. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-30352-9_42 · Cited by 2
Self-citation
Treating obstetric antiphospholipid syndrome
Galarza-Maldonado, C. M., Kourilovitch, M., Andrade-Sánchez, P., Durán, M. C., & Asanza, E. (2013) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.13.25 · Cited by 2
Le syndrome des antiphospholipides obstétrical : quelle est la place d’un traitement complémentaire à la combinaison aspirine et héparine ?
MEKINIAN, A., Kayem, G., Cohen, J., Carbillon, L., Abisror, N., JOSSELIN-MAHR, L., Bornes, M., & Fain, O. (2017) · Gynécologie Obstétrique Fertilité & Sénologie · doi:10.1016/j.gofs.2016.12.010 · Cited by 2
Autoimmune connective tissue diseases and pregnancy
Arese, V., Murabito, P., Ribero, S., Panzone, M., Tonella, L., Fierro, M. T., Papini, M., & Quaglino, P. (2019) · Giornale Italiano di Dermatologia e Venereologia · doi:10.23736/s0392-0488.18.06252-1 · Cited by 3
Thrombotic Microangiopathies in Pregnancy
Scully, M., & O’Brien, P. (2015) · Springer eBooks · doi:10.1007/978-3-319-15120-5_17 · Cited by 2
Management in maternal autoantibody-mediated clinical foetal myocardial disease
Murlewska, J., Preis, K., Słodki, M., Strzelecka, I., Smolewska, E. B., & Respondek‐Liberska, M. (2019) · Prenatal Cardiology · doi:10.5114/pcard.2019.91001 · Cited by 2
Síndrome antifosfolipídico obstétrico
(2021) · Revista Uruguaya de Medicina Interna · doi:10.26445/06.02.5 · Cited by 2
Antiphospholipid syndrome and recurrent pregnancy losses
Erra, R., Trespìdi, L., Ossola, W., & Luigi, M. P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90805-4.00008-0 · Cited by 1
Seronegative Antiphospholipid Syndrome: A Challenging Case Report
Subahi, E. A., Aboukhalaf, S., Mohammedain, S., Sayed, S., Ali, E., Subahi, M., & Kamal, I. (2024) · Clinical Case Reports · doi:10.1002/ccr3.9585 · Cited by 1
Navigating obstetric antiphospholipid syndrome: pathophysiology, diagnosis, and therapeutic advances
Aldabie, G., Almarzooqi, A. M., Aljohani, R., Altawash, M. M., Alkadi, A., & Khamashta, M. A. (2026) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2025.2612589 · Cited by 1
Self-citation
Current treatment strategies for management of antiphospholipid syndrome
Reggia, R., Andréoli, L., Tincani, A., & Shoenfeld, Y. (2014) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2014.881734 · Cited by 1
OBSTETRIC ANTIPHOSPHOLIPID SYNDROME - A REVIEW
Schreiber, K. I., Ateka–Barrutia, O., Khamashta, M. A., & Hughes, G. (2011) · Fetal and Maternal Medicine Review · doi:10.1017/s0965539511000131 · Cited by 1
Self-citation
The Pathogenic Mechanisms for Antiphospholipid Antibodies (aPL)-Mediated Pregnancy Loss
Simone, N. D., & D’Ippolito, S. (2014) · Rare diseases of the immune system · doi:10.1007/978-3-319-11044-8_4 · Cited by 1
Use of plasmapheresis in treatment of patients with unfavorable anamnestic pregnancy outcomes coupled to antiphospholipid antibodies
Еремеева, Д. Р., Зайнулина, М. С., Dolgova, Y. S., Шахалиев, Р. А., Сильванович, О. А., & Pavlova, L. A. (2021) · Obstetrics Gynecology and Reproduction · doi:10.17749/2313-7347/ob.gyn.rep.2021.105 · Cited by 1
Study of the Effect of Intralipid Infusion during Pregnancy as an Additive Treatment for Reducing Pregnancy Complications Caused by Antiphospholipid Antibody Syndrome
El-Gegawy, A. E., Lotfy, H. A., & Elshwaikh, S. L. (2021) · Open Journal of Obstetrics and Gynecology · doi:10.4236/ojog.2021.114033 · Cited by 1
Triple Positive Antiphospholipid Antibody Syndrome in Pregnancy with High Frequency Plasma Exchange: A Case Report
Cottrell, J. N., Alsanani, A., Ogu, I., & Chaffin, D. G. (2022) · Transfusion Medicine and Hemotherapy · doi:10.1159/000526349 · Cited by 1
Mitral Valve Replacement for Enlarged Libman-Sacks Endocarditis in a Patient with Persistent Primary Antiphospholipid Syndrome and Recurrent Stroke: A Case Report
Takeuchi, K., Izumi, T., Nanaura, H., Yamada, N., Hayata, Y., Obayashi, C., & Sugie, K. (2023) · American Journal of Case Reports · doi:10.12659/ajcr.938930 · Cited by 1
Abortion adverse events associated with adalimumab, etanercept, ustekinumab, and dupilumab during pregnancy: A pharmacovigilance study based on FDA adverse event reporting system
Liu, Q., Wang, Y., Hu, P., & He, P. (2025) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2025.01043 · Cited by 1
Nuevas estrategias en el tratamiento del síndrome antifosfolípido
Ibañez, S., Iruretagoyena, M., & GUTIÉRREZ-ESTRADA, M. A. (2013) · Revista médica de Chile · doi:10.4067/s0034-98872013000800011 · Cited by 1
Dealing with refractoriness in obstetric primary antiphospholipid syndrome—often not a matter of success
Andrés, M., Marco, P., Perdiguero, M., Pascual, E., & Vela, P. (2014) · Lupus · doi:10.1177/0961203314536250 · Cited by 1
Pregnancy Morbidity Associated with Thrombophilias: Recurrent Miscarriage
Rai, R., & Regan, L. (2015) · Springer eBooks · doi:10.1007/978-3-319-15120-5_7
Preventing Pregnancy Loss in Women with Antiphospholipid Antibody Syndrome
Green, D. (2011) · Journal watch · doi:10.1056/oh201108020000001
planning, and treatment during the pregnancy, postpartum and breastfeeding period in patients with antiphospholipid syndrome
Ostanek, L., Majdan, M., Olesińska, M., Kosowicz, M., Teliga-Czajkowska, J., & Wiland, P. (2014) · Reumatologia/Rheumatology · doi:10.5114/reum.2014.41448
The Antiphospholipid Syndrome in Pregnancy: A Review Article
Cacciola, R. R., Cacciola, E. G., & Cacciola, E. (2015)
The Impact of aPL Detection on Pregnancy
Bertero, M. T., Kuzenko, A., & Bazzan, M. (2016) · Rare diseases of the immune system · doi:10.1007/978-3-319-24535-5_13
Treatment of Pregnancy Complications in Antiphospholipid Syndrome
Nassar, A. H., Uthman, I. W., Eid, J., & Khamashta, M. A. (2016) · Technical report · doi:10.1016/b978-0-444-63655-3.00018-1
Self-citation
Pregnancy Morbidity Associated with Hereditary and Acquired Thrombophilias: Recurrent Miscarriage
Rai, R., & Regan, L. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4411-3_5
Management of antiphospholipid syndrome in adults: The European League Against Rheumatism (EULAR) recommendations
Veselinović, M., Lucic, A. T., Jakovljevic, V. L., & Aničić, A. (2019) · Medicinski casopis · doi:10.5937/mckg53-23292
Maladies de système
(2014) · Elsevier eBooks · doi:10.1016/b978-2-294-71330-9.00002-7
Treatment of Antiphospholipid Syndrome
Sciascia, S., & Khamashta, M. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801917-7.00063-2
Self-citation
Obstetric Antiphospholipid Syndrome
Hoxha, A., & Simioni, P. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101804
Antiphospholipid syndrome: How to manage pregnancy?
Service de Gynécologie et Obstétrique, H. M. D. M. V., Moukit, M., Kouach, J., Aitbouhou, R., Hassani, M. E. M. E., Babahabib, A., Rahali, D. M., & Dehayni, M. (2017) · Batna Journal of Medical Sciences (BJMS) · doi:10.48087/bjmsra.2017.4203
Autoimmune rheumatic disorders and vasculitis in pregnancy
Soh, M. C., & Nelson‐Piercy, C. (2020) · doi:10.1093/med/9780198746690.003.0276
Self-citation
Treatment of antiphospholipid syndrome
Sciascia, S., & Khamashta, M. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814551-7.00065-9
Self-citation
Síndrome antifosfolípido
Grande, C. S., Sánchez, L. V., Valero-Expósito, M., & Villanueva, M. J. G. (2017) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2017.02.001
In brief
(2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.120
Collagen Vascular Diseases in Pregnancy
Carpenter, J. R., & Branch, D. W. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-32108-2.00046-9
Efficacy of Hydroxychloroquine for Improving Pregnancy Outcomes in a Female with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
Takaki, Y., Daimon, A., Nunode, M., Tanaka, T., Fujita, D., & Ohmichi, M. (2022) · Case Reports in Obstetrics and Gynecology · doi:10.1155/2022/5612091
Rheumatologische Krankheiten und Schwangerschaft: Systemischer Lupus erythematodes, Antiphospholipidsyndrom, rheumatoide Arthritis, Spondyloarthritis, systemische Sklerose, entzündliche Myopathien und Vaskulitis
Förger, F., & Mayer-Pickel, K. I. (2022) · Springer Reference Medizin · doi:10.1007/978-3-662-44369-9_72-1
Maladies de système
Benachi, A., Luton, D., Mandelbrot, L., & Picone, O. (2022) · Elsevier eBooks · doi:10.1016/b978-2-294-77351-8.00002-x
Actualités dans la prise en charge de la grossesse chez les patientes ayant une biologie ou un syndrome des antiphospholipides
Guettrot-Imbert, G., Murarasu, A., Guern, V. L., & Costedoat-Chalumeau, N. (2023) · Revue du Rhumatisme · doi:10.1016/j.rhum.2023.10.010
SUCCESFUL PREGNANCY AND PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS (PPBL) - A CASE STUDY OF A RARE COEXISTANCEPreprint
Dryllis, G., Giannikos, T., Konstadinou, E., Moustakas, I. I., Christopoulos, P., Pittaras, T., Politou, M., & Valsami, S. I. (2024) · doi:10.22541/au.170665873.31012005/v1
ANÁLISE DAS MANIFESTAÇÕES CLÍNICAS E TRATAMENTO DA SÍNDROME DO ANTICORPO ANTIFOSFOLÍPIDE NA GESTAÇÃO: UMA REVISÃO DE LITERATURA
Leite, L. D. A., Ferraz, J. P. A., Ferraz, B. P. A., Batista, B. L. F., Filizola, C. C., Saraiva, P. R. B. D. C., Accioly, J. F. L., & de Souza, R. M. L. (2024) · Revista Contemporânea · doi:10.56083/rcv4n4-025
Rheumatologische Krankheiten und Schwangerschaft: Systemischer Lupus erythematodes, Antiphospholipidsyndrom, rheumatoide Arthritis, Spondyloarthritis, systemische Sklerose, entzündliche Myopathien und Vaskulitis
Förger, F., & Mayer-Pickel, K. I. (2024) · Springer Reference Medizin · doi:10.1007/978-3-662-63506-3_72
The Role of Immunotherapy in the Treatment of Recurrent Miscarriage
Panah, S. R., & Mohammadi, H. (2023) · ملیون. · doi:10.61186/sjrm.8.1.43
Case Report: The case of atypical OAPS complicated by positive anti-SSA and anti-SSB antibodies
Huang, C., Hong, D., & Chen, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1631323
Antiphospholipid syndrome and pregnancy—a hematologic perspective
Doyle, A. J., Cox, C., & Breen, K. A. (2026) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2026.103396
Antiphospholipid Syndrome and Pregnancy
Zucchi, D., Ciribè, B., Tani, C., & Mosca, M. (2026) · Springer eBooks · doi:10.1007/978-981-95-9581-5_8
Rheumatological Diseases: Systemic Lupus Erythematosus, Antiphospholipid Syndrome, Rheumatoid Arthritis, Spondyloarthritis, Systemic Sclerosis, Inflammatory Myopathies and Vasculitis
Förger, F., & Mayer-Pickel, K. I. (2026) · Springer eBooks · doi:10.1007/978-3-662-70578-0_35
Síndrome antifosfolípide obstétrica Número 6 – Junho 2021
de Barros, V. I. P. V. L., Igai, A. M. K., de Oliveira, A. L. M. L., Teruchkin, M. M., & Orsi, F. A. (2021) · Femina · doi:10.61622/0100-7254496202106
Comment gérer la grossesse et l'allaitement d'une patiente lupique et/ou ayant un syndrome des antiphospholipides ?
Guettrot-Imbert, G., & Costedoat-Chalumeau, N. (2013) · Elsevier eBooks · doi:10.1016/b978-2-294-71447-4.50021-0
Treatment of Pregnancy Complications
Acaia, B., Rossi, F., & Chighizola, C. B. (2014) · Rare diseases of the immune system · doi:10.1007/978-3-319-11044-8_16

Authors: Bramham, K., Thomas, M., Nelson-Piercy, C., Khamashta, M., & Hunt, B. J.
Affiliations: King's College London (GB)
National Health Service (GB)
Obstetric Medicine, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom;
Guy's and St Thomas' NHS Foundation Trust (GB)
Corresponding author: Bramham, Kate
Thomas, Mari
ORCID: Bramham, Kate
Thomas, Mari
Khamashta, Munther
Hunt, Beverley J.
Venue: Blood
Publisher: American Society of Hematology
Published: 2011-06-23
Volume: 117
Issue: 25
Pages: 6948-6951
ISSN: 0006-4971 (ISSN-L)
1528-0020
DOI: 10.1182/blood-2011-02-339234
OpenAlex: W2049326681
Cited by: 180
References: 27
Citations by year: 2026: 4 · 2025: 4 · 2024: 13 · 2023: 7 · 2022: 13 · 2021: 10 · 2020: 17 · 2019: 19 · 2018: 12 · 2017: 13 · 2016: 17 · 2015: 15 · 2014: 15 · 2013: 10 · 2012: 6
FWCI: 8.42
Type: journal article
Language: en
Open access: closed
Locations: Blood (publishedVersion)
PubMed (publishedVersion)
Research Portal (King's College London) (submittedVersion)
Funders: National Institute for Health and Care Research (DRF-2009-02-18)
British Heart Foundation (FS/10/013/28073)
Topics: Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords: antiphospholipid antibodies, miscarriage, low-dose prednisolone, aspirin, heparin, pregnancy outcomes, ectopic pregnancy, preterm birth, preeclampsia, small for gestational age
MeSH terms: Abortion, Spontaneous, Adult, Anti-Inflammatory Agents, Anticoagulants, Aspirin, Female, Heparin, Humans, Prednisolone, Pregnancy, Pregnancy Trimester, First, Antiphospholipid Syndrome, Antibodies, Antiphospholipid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks